Biodesix (BDSX) Free Cash Flow (2019 - 2026)

Biodesix (BDSX) has reported Free Cash Flow for 8 consecutive years, with -$10.2 million the latest figure, recorded in Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$10.2 million, down 18.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$25.1 million (up 44.23% YoY), and the FY2025 annual result was -$23.5 million, up 54.64% from the prior year.
• Free Cash Flow was -$10.2 million for Q1 2026 at Biodesix, down from $692000.0 in the prior quarter.
• Over five years, Free Cash Flow peaked at $692000.0 in Q4 2025 and troughed at -$20.5 million in Q2 2024.
• Average Free Cash Flow over 5 years is -$10.6 million, with a median of -$10.2 million recorded in 2026.
• Year-over-year, Free Cash Flow sank 1326.58% in 2022 and jumped 114.02% in 2025.
• Over 5 years, Free Cash Flow stood at -$13.9 million in 2022, then retreated by 10.01% to -$15.3 million in 2023, then surged by 67.68% to -$4.9 million in 2024, then surged by 114.02% to $692000.0 in 2025, then sank by 1581.07% to -$10.2 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$10.2 million in Q1 2026, $692000.0 in Q4 2025, and -$8.9 million in Q3 2025.